Goldman Sachs’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-28,947
| Closed | -$14K | – | 4770 |
|
|
2016
Q1 | $14K | Sell |
28,947
-75,789
| -72% | -$36.7K | ﹤0.01% | 4414 |
|
|
2015
Q4 | $71K | Buy |
104,736
+6,900
| +7% | +$4.68K | ﹤0.01% | 4082 |
|
|
2015
Q3 | $95K | Sell |
97,836
-55,386
| -36% | -$53.8K | ﹤0.01% | 4190 |
|
|
2015
Q2 | $184K | Sell |
153,222
-4,034
| -3% | -$4.84K | ﹤0.01% | 4049 |
|
|
2015
Q1 | $167K | Sell |
157,256
-59,838
| -28% | -$63.5K | ﹤0.01% | 3972 |
|
|
2014
Q4 | $237K | Sell |
217,094
-155,274
| -42% | -$170K | ﹤0.01% | 3869 |
|
|
2014
Q3 | $403K | Sell |
372,368
-61,152
| -14% | -$66.2K | ﹤0.01% | 3463 |
|
|
2014
Q2 | $450K | Sell |
433,520
-11,666
| -3% | -$12.1K | ﹤0.01% | 3421 |
|
|
2014
Q1 | $459K | Sell |
445,186
-54,063
| -11% | -$55.7K | ﹤0.01% | 3430 |
|
|
2013
Q4 | $579K | Buy |
499,249
+173,716
| +53% | +$201K | ﹤0.01% | 3346 |
|
|
2013
Q3 | $547K | Buy |
325,533
+15,297
| +5% | +$25.7K | ﹤0.01% | 3290 |
|
|
2013
Q2 | $620K | Buy |
+310,236
| New | +$620K | ﹤0.01% | 3046 |
|